OmniAb Inc
NASDAQ:OABI
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.65
6.69
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one OABI stock under the Base Case scenario is 4.35 USD. Compared to the current market price of 3.92 USD, OmniAb Inc is Undervalued by 10%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
OmniAb Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for OABI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
OmniAb Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
OmniAb Inc
Balance Sheet Decomposition
OmniAb Inc
Current Assets | 66.6m |
Cash & Short-Term Investments | 59.4m |
Receivables | 3.5m |
Other Current Assets | 3.7m |
Non-Current Assets | 264.9m |
PP&E | 34.7m |
Intangibles | 228.1m |
Other Non-Current Assets | 2.2m |
Current Liabilities | 14.4m |
Accounts Payable | 2.2m |
Accrued Liabilities | 8.7m |
Other Current Liabilities | 3.5m |
Non-Current Liabilities | 25.4m |
Other Non-Current Liabilities | 25.4m |
Earnings Waterfall
OmniAb Inc
Revenue
|
20.4m
USD
|
Operating Expenses
|
-100.2m
USD
|
Operating Income
|
-79.8m
USD
|
Other Expenses
|
16.8m
USD
|
Net Income
|
-63m
USD
|
Free Cash Flow Analysis
OmniAb Inc
USD | |
Free Cash Flow | USD |
OABI Profitability Score
Profitability Due Diligence
OmniAb Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
OmniAb Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
OABI Solvency Score
Solvency Due Diligence
OmniAb Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
OmniAb Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OABI Price Targets Summary
OmniAb Inc
According to Wall Street analysts, the average 1-year price target for OABI is 9.95 USD with a low forecast of 8.08 USD and a high forecast of 12.6 USD.
Dividends
Current shareholder yield for OABI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
OABI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
OmniAb, Inc. operates as a drug discovery company. The company is headquartered in Emeryville, California and currently employs 93 full-time employees. The company went IPO on 2020-10-09. The OmniAb platform is the biological intelligence (BI) of transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences to facilitate the development of human therapeutic candidates. Its OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications through a common light chain approach and OmniTaur features structural attributes of cow antibodies for complex targets. The firm's OmniChicken and OmniClic offer affinity-matured antibodies in an evolutionarily distant chicken host environment, which can deliver a diverse repertoire of antibody panels to conserved therapeutic targets.
Contact
IPO
Employees
Officers
The intrinsic value of one OABI stock under the Base Case scenario is 4.35 USD.
Compared to the current market price of 3.92 USD, OmniAb Inc is Undervalued by 10%.